Chloroethylclonidine

Chloroethylclonidine is a chemical compound that acts as an alpha-adrenergic receptor antagonist. It is primarily used in research settings to study the function of adrenergic receptors and their role in the sympathetic nervous system.
Chemical Properties[edit]
Chloroethylclonidine is a derivative of clonidine, a well-known alpha-2 adrenergic receptor agonist. The addition of a chloroethyl group modifies its activity, allowing it to act as an irreversible antagonist at certain adrenergic receptors. This makes it a valuable tool in pharmacological research for dissecting the roles of different receptor subtypes.
Mechanism of Action[edit]
Chloroethylclonidine binds covalently to the alpha-1 adrenergic receptor subtypes, particularly the alpha-1B adrenergic receptor. This irreversible binding leads to a long-lasting blockade of receptor activity, which can be useful in experiments designed to understand the physiological and pathological roles of these receptors.
Research Applications[edit]
In research, chloroethylclonidine is used to:
- Investigate the role of alpha-1 adrenergic receptors in cardiovascular physiology.
- Study the effects of adrenergic receptor blockade in hypertension and other cardiovascular diseases.
- Explore the involvement of adrenergic receptors in neurotransmitter release and neurotransmission.
Safety and Handling[edit]
As with many research chemicals, chloroethylclonidine should be handled with care. Appropriate laboratory safety protocols should be followed, including the use of personal protective equipment (PPE) such as gloves and goggles.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian